What happened
Shares of CTI BioPharma (NASDAQ: CTIC) moved sharply higher after the drugmaker reported first-quarter results Friday morning. Investors were pleased with the initial sales figures for Vonjo, its first approved drug, and pushed the stock price 20.8% higher as of 11:
Why CTI Biopharma Stock Is Surging Today
More Stories
Young, Famous & African's Peace Hyde: From teacher to Netflix hitmaker
S&P 500 Nears Trendline With Historic Buying Opportunity
Terra ecosystem collapses, Sam Bankman-Fried buys Robinhood stock and crypto trader receives jail sentence for Ponzi scheme: Hodler’s Digest, May 8-14